胃肠癌的基于外体的治疗术:生物标志物发现和治疗工程的进步
Mohit J Mehta1,2, Dongjun Shin1, Hyun Sung Park1
1Department of Biological Sciences and Bioengineering, Inha University, 100 Inha-ro, Michuhol-gu, Incheon, 22212, Republic of Korea.
Small methods
|February 26, 2025
概括
外体细胞在胃肠道 (GI) 癌症中表现有前途,作为诊断生物标志物和治疗载体. 本综述探讨了早期检测,治疗和克服胃肠道癌症药物耐药性的外体潜力.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 纳米技术 纳米技术
背景情况:
- 外体是胃肠癌管理中的关键生物分子.
- 它们为当前的诊断和治疗局限性提供了解决方案.
研究的目的:
- 探索肠道癌症的基于外体的技术.
- 强调它们在诊断和治疗中的作用.
主要方法:
- 研究的外体生物标记物 (miRNAs, lncRNAs,circRNAs,蛋白质) 用于诊断用途.
- 检查了外体源,净化和用于治疗增强的工程.
主要成果:
- 外体生物标志物在诊断准确性,早期检测和预后方面显示出潜力.
- 工程外体可以调节免疫反应,克服耐药性,并抑制转移.
结论:
- 外体提供了一个有希望的治疗肠道癌症的治疗方法.
- 需要进一步的研究来克服挑战,并推进基于外体细胞的疗法.
相关概念视频
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K